[1] 张兰芳,齐晓勇,贾新未,等.不同剂量瑞舒伐他汀对急性心肌梗死经皮冠状动脉介入治疗患者心肌再灌注及心功能的影响[J].中国临床药理学杂志,2015,31(13):1223-1226. [2] 杨建军,牟华明,庞小华,等.瑞舒伐他汀对急性ST段抬高型心肌梗死患者介入治疗后动脉粥样硬化及炎症反应的影响[J].中国老年学杂志,2016,36(14):3443-3444. [3] Qu Y,Zhao HY,Wang DY,et al.NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins[J].Coron Artery Dis,2015,26(5):409-421. [4] 中华医学会心血管病学分会.急性心肌梗死诊断和治疗指南[J].中华心血管杂志,2001,29(12):710-713. [5] 刘科卫,李晓燕,张国明.不同剂量瑞舒伐他汀对急性心肌梗死择期介入治疗患者近中期预后的影响[J].第三军医大学学报,2013,35(6):576-579. [6] Pauriah M, Elder DH, Ogston S, et al. High-potency statin and ezetimibe use and mortality in survivors of an acute myocardial infarction: a population-based study[J].Heart,2014,100(11):867-872. [7] 郭素萍,张霞,高传玉.大剂量瑞舒伐他汀对急性心肌梗死患者血清高敏C反应蛋白、MMP-9及心功能的影响[J].郑州大学学报(医学版),2013,48(6):836-838. [8] 张玉英,陶志刚.大剂量瑞舒伐他汀治疗急性心肌梗死患者血清GDF-15、hs-CRP水平变化及临床意义[J].山东医药,2017,57(17):75-77. [9] 高刻.大剂量瑞舒伐他汀对急性心肌梗死患者血清MMP-9、hs-CRP及心室重构的影响[J].海南医学,2015,26(19):2821-2823. [10] Alnouri F, Wood D, Kotseva K, et al. Which statin worked best to achieve lipid level targets in a European registry:A post-hoc analysis of the EUROASPIRE Ⅲ for coronary heart disease patients[J].J Saudi Heart Assoc,2014,26(4):183-191. [11] 赵文萍,张兰芳,冯惠平,等.两种剂量瑞舒伐他汀对急性心肌梗死患者血清心肌营养素1水平及心功能的影响[J].中国医药,2014,9(12):1735-1737. [12] Xu YJ,Yang HY,Qian YD,et al.Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts[J].Circ J,2011,75(6):1476-1485. [13] 牛俊芳,李佳.两种剂量瑞舒伐他汀治疗急性心肌梗死的疗效比较[J].心脏杂志,2014,26(5):558-561. [14] 赵莉,王晨霞,高智耀.不同剂量瑞舒伐他汀对急性心肌梗死患者心功能的影响[J].临床和实验医学杂志,2015,14(20):1698-1700. [15] Sun XX,Xie ZY,Huang JG, et al. Rosuvastatin changes cytokine expressions in ischemic territory and preserves heart function after acute myocardial infarction in rats[J].J Cardiovasc Pharmacol Ther,2013,18(2):162-176.
2018, Vol. 35 
